These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34539302)

  • 1. Relationship between cerebrospinal fluid protein level and electrophysiologic abnormalities in the acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barré syndrome.
    Jawaid W; Sana R; Umer SR; Nisa Q; Butt M; Shahbaz N
    Ger Med Sci; 2021; 19():Doc12. PubMed ID: 34539302
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.
    Das S; Khan RK; Alam SM; Chowdhury NH; Das P
    Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Autonomic Dysfunction in Patients of Guillain Barre Syndrome in a Tertiary Care Hospital.
    Singh J; Raja V; Irfan M; Hashmat O; Syed M; Shahbaz NN
    Cureus; 2020 Dec; 12(12):e12101. PubMed ID: 33489518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in electrophysiological findings suggestive of demyelination following Guillain-Barré syndrome: A retrospective study.
    Guémy C; Durand MC; Brisset M; Nicolas G
    Muscle Nerve; 2023 May; 67(5):394-400. PubMed ID: 36814082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome.
    DiCapua DB; Lakraj AA; Nowak RJ; Robeson K; Goldstein J; Patwa H
    J Clin Neuromuscul Dis; 2015 Dec; 17(2):47-51. PubMed ID: 26583489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and nerve conduction features in Guillain-Barré syndrome associated with Zika virus infection in Cúcuta, Colombia.
    Uncini A; González-Bravo DC; Acosta-Ampudia YY; Ojeda EC; Rodríguez Y; Monsalve DM; Ramírez-Santana C; Vega DA; Paipilla D; Torres L; Molano-González N; Osorio JE; Anaya JM
    Eur J Neurol; 2018 Apr; 25(4):644-650. PubMed ID: 29266602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
    Capodivento G; De Michelis C; Carpo M; Fancellu R; Schirinzi E; Severi D; Visigalli D; Franciotta D; Manganelli F; Siciliano G; Beronio A; Capello E; Lanteri P; Nobile-Orazio E; Schenone A; Benedetti L; Nobbio L
    J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):303-310. PubMed ID: 33093191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenic relevance of α
    Dong C; Palladino SP; Helton ES; Ubogu EE
    Acta Neuropathol; 2016 Nov; 132(5):739-752. PubMed ID: 27460017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early electrophysiological findings in acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barre syndrome in the Pakistani population - a comparison with global data.
    Wali A; Kanwar D; Khan SA; Khan S
    J Peripher Nerv Syst; 2017 Dec; 22(4):451-454. PubMed ID: 29091318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Cerebrospinal Fluid Uric Acid Levels in Guillain-Barré Syndrome.
    Chang SH; Tian XB; Wang J; Liu MQ; Huang CN; Qi Y; Zhang LJ; Gao CL; Zhang DQ; Sun LS; Yang L
    Front Neurol; 2020; 11():589928. PubMed ID: 33281729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CSF Total Protein with Clinical Heterogeneity, Disease Severity and Electrophysiological Pattern in GBS Patients.
    Rahaman H; Rahman HZ; Emran MM; Rahman MA
    Mymensingh Med J; 2024 Apr; 33(2):496-500. PubMed ID: 38557532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.
    Ziganshin RH; Ivanova OM; Lomakin YA; Belogurov AA; Kovalchuk SI; Azarkin IV; Arapidi GP; Anikanov NA; Shender VO; Piradov MA; Suponeva NA; Vorobyeva AA; Gabibov AG; Ivanov VT; Govorun VM
    Mol Cell Proteomics; 2016 Jul; 15(7):2366-78. PubMed ID: 27143409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with Clinical Outcomes of Guillain-Barre Syndrome Variants.
    Bano S; Nawaz A; Nasim A; Numan A; Zahid M
    J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Pashenkov M; Jin JP; Link H
    J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologic-pathologic correlation in Guillain-Barré syndrome in children.
    Lu JL; Sheikh KA; Wu HS; Zhang J; Jiang ZF; Cornblath DR; McKhann GM; Asbury AK; Griffin JW; Ho TW
    Neurology; 2000 Jan; 54(1):33-9. PubMed ID: 10636122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology.
    Bourque PR; Brooks J; Warman-Chardon J; Breiner A
    J Neurol; 2020 Mar; 267(3):746-751. PubMed ID: 31734909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antibody to VacA of Helicobacter pylori in cerebrospinal fluid from patients with Guillain-Barre syndrome.
    Chiba S; Sugiyama T; Yonekura K; Tanaka S; Matsumoto H; Fujii N; Ebisu S; Sekiguchi K
    J Neurol Neurosurg Psychiatry; 2002 Jul; 73(1):76-8. PubMed ID: 12082053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
    Wang XK; Zhang HL; Meng FH; Chang M; Wang YZ; Jin T; Mix E; Zhu J
    Neurol Sci; 2013 May; 34(5):655-61. PubMed ID: 22526766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barré syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy?
    Weller M; Stevens A; Sommer N; Wiethölter H
    Eur Arch Psychiatry Clin Neurosci; 1992; 242(2-3):122-6. PubMed ID: 1486101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.